Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer--response

Clin Cancer Res. 2014 Apr 15;20(8):2237. doi: 10.1158/1078-0432.CCR-13-3391. Epub 2014 Mar 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • DNA Repair / drug effects*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Phthalazines / therapeutic use*
  • Poly(ADP-ribose) Polymerase Inhibitors*
  • Small Cell Lung Carcinoma / drug therapy*

Substances

  • Phthalazines
  • Poly(ADP-ribose) Polymerase Inhibitors